1. Home
  2. LAES vs ESPR Comparison

LAES vs ESPR Comparison

Compare LAES & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SEALSQ Corp

LAES

SEALSQ Corp

HOLD

Current Price

$4.14

Market Cap

366.0M

Sector

Technology

ML Signal

HOLD

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.95

Market Cap

898.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LAES
ESPR
Founded
2022
2008
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
366.0M
898.5M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
LAES
ESPR
Price
$4.14
$3.95
Analyst Decision
Strong Buy
Buy
Analyst Count
2
6
Target Price
$6.50
$6.67
AVG Volume (30 Days)
9.9M
6.5M
Earning Date
12-11-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$10,978,000.00
$303,802,000.00
Revenue This Year
N/A
$25.45
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2.83
52 Week Low
$1.99
$0.69
52 Week High
$11.00
$4.13

Technical Indicators

Market Signals
Indicator
LAES
ESPR
Relative Strength Index (RSI) 44.12 59.47
Support Level $4.03 $3.63
Resistance Level $4.76 $4.13
Average True Range (ATR) 0.36 0.20
MACD 0.01 -0.02
Stochastic Oscillator 22.13 64.00

Price Performance

Historical Comparison
LAES
ESPR

About LAES SEALSQ Corp

SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. The company's vaultIC range offers a set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: